BHOCBiological Hemoglobin Oxygen Carrier
Pencil and watercolor study of donor and recipient, heart, lungs, liver and kidney around an organ preparation chamber; a pig and DNA illustrate the separate xenograft path, and a small cabinet bioreactor contains a growing tissue construct
Illustrative research pathways. Human donation, xenotransplantation and bioengineered grafts follow different protocols; the image does not show a proven BHOC treatment.
Before · During · After transplantation

Oxygen continuity. Across every transition.

BHOC Transplant explores how BHOC (Biological Hemoglobin Oxygen Carrier), a cell-free hemoglobin-based oxygen carrier, could support oxygen delivery during organ preservation, machine perfusion and transplantation. Its research follows oxygen continuity from donor care through ex vivo organ support to recipient recovery. Each stage requires its own evidence and protocol.

Research concept across separate donor, ex-vivo and recipient protocols. A P50 near 40 mmHg at 37°C is described for historical HBOC-201; product-specific BHOC behavior, transplant outcomes and time gained remain to be established.

One organ. One protocol. A measurable question.

Begin with product characterization and controlled ex-vivo work, then assess further pathways separately.

Discuss collaboration ↗